We are excited that two patients have been enrolled in the Phase I trial: PET Imaging of Tissue Factor (TF) Expression in Patients with Primary and Metastatic Cancer Using 18F-ASIS (clinicaltrials.gov).

The inclusion of the first patients marks the clinical translation of our preclinical collaborative project on tissue factor imaging together with the Department of Clinical Physiology, Nuclear Medicine and PET. The project received funding for Innovation Fund Denmark. The preclinical development was previously published in JNM (article).